Upcoming Webinar: Accelerating Rare Disease Drug Development with Wearable DHTs

Join us April 26, 2023 | 11 AM ET

In this webinar, we will explore how sensor-based digital health technologies (DHTs), such as low-burden wearable devices, offer new opportunities to advance rare disease research. Speakers include digital health experts from ActiGraph, Bellerophon Therapeutics, and IQVIA.

Introducing ActiGraph LEAP™

Next Generation Multisensor Wearable for Patient-Centered Clinical Research 

Unlock new and deeper insights into how clinical trial participants function in the real world with our most advanced wearable ever. ActiGraph LEAP features one of the most comprehensive sensor collections in the industry, providing continuous digital measures of activity, sleep, mobility, and vital signs,* including heart rate and variability, oxygen saturation, blood pressure, and skin temperature, in a single fit-for-purpose device. 

*vital sign measures for investigational use only

The Clear Choice for Philips Actiwatch Users

Explore ActiGraph’s Wearable Technology Solutions

As Philips discontinues the Actiwatch product line, many Actiwatch users need an alternative to meet their research needs. ActiGraph's line of FDA-cleared, medical grade wearable devices can provide all common digital outcome measures of sleep, physical activity, and mobility with high concordance to Actiwatch device data.

Clinical Operations Solutions for DHTs

Achieve the Best Results from Your Digital Health Technology Investment

Many study teams struggle with the operational complexities of deploying DHTs into large-scale, global clinical trials. ActiGraph’s experienced Digital Health Operations team provides end-to-end operational support, helping clients overcome the challenges of technology implementation and optimize the collection of clinically meaningful outcome measures.